Ariad Written Description Ruling Could Significantly Impact Biotech Patents
Ariad Written Description Ruling Could Significantly Impact Biotech Patents
The fate of many chemical and biotechnology patents will soon depend on the Federal Circuit's interpretation of the first paragraph of section 112 of the Patent Act.